Aspire Biopharma Holdings (ASBP) Metrics: History & Chart

Aspire Biopharma Holdings, Inc.(ASBP)

Biotechnology · Estero, FL

$8.88+0.10 (+1.14%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.

Estero, FL

2 employees

aspirebiolabs.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Kraig T. Higginson

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+4.47%
30D Total Return	+0.11%
YTD Total Return	-94.39%
1Y Total Return	-98.07%
3Y Total Return	-99.93%
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-94.39%
2025	-98.85%
2024	+5.60%
2023	+5.73%
2022	N/A
2021	N/A

CAGR TTM	-98.04%
CAGR 3Y	-91.13%
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	81700.55
PE Ratio Avg TTM	84861.46
PE Ratio Avg 3Y	281427.36
Current VS TTM Avg	-3.72%
Current VS 3Y Avg	-70.97%
Current VS 5Y Avg	-70.97%

All Metrics

ASBP Valuation Metrics

ASBP Stock Price Metrics

ASBP Dividend Metrics

ASBP Growth Rate Metrics

ASBP Discounted Cash Flow Metrics

ASBP Returns By Period

ASBP Yearly Returns

ASBP Average Annual Returns By Period (CAGR)

ASBP Revenue Metrics

ASBP PE Ratio Metrics

ASBP PS Ratio Metrics

ASBP PB Ratio Metrics

ASBP Price to Free Cash Flow Ratio Metrics

ASBP Debt to Equity Ratio Metrics

ASBP PEG Ratio Metrics

ASBP FCF Yield

ASBP Earnings Yield

ASBP EBITDA Yield

ASBP OCF Yield

ASBP EV/EBIT Ratio Metrics

ASBP EV/EBITDA Ratio Metrics

ASBP EV/Assets Ratio Metrics

ASBP EV/Sales Ratio Metrics

ASBP Current Ratio Metrics

ASBP Quick Ratio Metrics

ASBP ROIC Metrics

ASBP Return on Assets Metrics

ASBP Return on Equity Metrics

ASBP Net Profit Margin Metrics

ASBP Gross Profit Margin Metrics

ASBP Tax Rate Metrics

PS Ratio	94.37
PS Ratio Avg TTM	10252.04
PS Ratio Avg 3Y	10252.04
Current VS TTM Avg	-99.08%
Current VS 3Y Avg	-99.08%
Current VS 5Y Avg	-99.08%

PB Ratio	0.78
PB Ratio Avg TTM	1.81
PB Ratio Avg 3Y	7250.33
Current VS TTM Avg	-56.83%
Current VS 3Y Avg	-99.99%
Current VS 5Y Avg	-99.99%

PFCF Ratio	60609.91
PFCF Ratio Avg TTM	60791.74
PFCF Ratio Avg 3Y	60791.74
Current VS TTM Avg	-0.30%
Current VS 3Y Avg	-0.30%
Current VS 5Y Avg	-0.30%

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	(0.41)
Debt/Equity Ratio Avg 3Y	(0.23)
Current VS TTM Avg	+100.00%
Current VS 3Y Avg	+100.00%
Current VS 5Y Avg	+100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.00%
FCF Yield Avg TTM	0.00%
FCF Yield Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	0.00%
Earnings Yield Avg TTM	0.00%
Earnings Yield Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	1.51
Ev/Ebitda Ratio Avg TTM	1.21
Ev/Ebitda Ratio Avg 3Y	1.21
Current VS TTM Avg	+24.51%
Current VS 3Y Avg	+24.51%
Current VS 5Y Avg	+24.51%

Ev/Assets Ratio	0.88
Ev/Assets Ratio Avg TTM	36.51
Ev/Assets Ratio Avg 3Y	2529.38
Current VS TTM Avg	-97.59%
Current VS 3Y Avg	-99.97%
Current VS 5Y Avg	-99.90%

Ev/Sales Ratio	181.49
Ev/Sales Ratio Avg TTM	24367.75
Ev/Sales Ratio Avg 3Y	24367.75
Current VS TTM Avg	-99.26%
Current VS 3Y Avg	-99.26%
Current VS 5Y Avg	-99.26%

Current Ratio	7.99
Current Ratio Avg TTM	2.14
Current Ratio Avg 3Y	0.19
Current VS TTM Avg	+273.75%
Current VS 3Y Avg	+4214.82%
Current VS 5Y Avg	+646.13%

Quick Ratio	7.81
Quick Ratio Avg TTM	2.07
Quick Ratio Avg 3Y	0.18
Current VS TTM Avg	+277.19%
Current VS 3Y Avg	+4205.91%
Current VS 5Y Avg	+636.00%

ROIC	(59.81%)
ROIC Avg 3Y	(120.90%)
ROIC Avg 5Y	(22.21%)
Current VS 3Y Avg	+50.53%
Current VS 5Y Avg	-169.25%
Current VS 10Y Avg	-169.25%

ROA	(81.60%)
ROA Avg TTM	(138.14%)
ROA Avg 3Y	(64.58%)
Current VS TTM Avg	+40.93%
Current VS 3Y Avg	-26.36%
Current VS 5Y Avg	-765.19%

ROE	(93.97%)
ROE Avg TTM	(199.02%)
ROE Avg 3Y	(149.99%)
Current VS TTM Avg	+52.78%
Current VS 3Y Avg	+37.35%
Current VS 5Y Avg	-982.28%

Net Profit Margin	(11314.24%)
Net Profit Margin Avg TTM	(43839.60%)
Net Profit Margin Avg 3Y	(200.96%)
Current VS TTM Avg	+74.19%
Current VS 3Y Avg	-5529.99%
Current VS 5Y Avg	N/A

Gross Profit Margin	(1.87%)
Gross Pft Margin Avg TTM	12.36%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	-115.12%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A